Vincerx Pharma Inc

VINCW:NASDAQ
RT Quote | NASDAQ | USD
Last | 4:00 PM EST
3.80quote price arrow up+0.20 (+5.56%)
Volume
37,697
52 week range
0.05 - 3,006.27

...

Loading . . .

KEY STATS

  • Open3.50
  • Day High3.99
  • Day Low3.30
  • Prev Close3.60
  • 52 Week High3,006.27
  • 52 Week High Date05/21/20
  • 52 Week Low0.05
  • 52 Week Low Date05/28/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vincerx Pharma Inc News

There is no recent news for this security.

Latest VINCW News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vincerx Pharma, Inc., formerly Vincera Pharma, Inc., is a clinical-stage life sciences company. The Company focuses on the development and oncology knowledge to advance new therapies for the treatment of cancer. The Company’s small molecule drug program includes VIP152, a clinical-stage positive transcription elongation factor beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. Its antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924...
Address
4500 Great American Parkway
Suite 100 #29
Santa Clara, CA
95054
United States